Stock Analysis on Net

CVS Health Corp. (NYSE:CVS)

Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

CVS Health Corp., consolidated balance sheet: assets (quarterly data)

US$ in millions

Microsoft Excel
Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cash and cash equivalents 8,196 13,043 13,807 14,618 12,945 17,197 12,116 8,442 9,408 9,826 7,119 5,598 7,854 9,256 14,869 10,081 5,683 5,193 6,063 5,896
Short-term investments 3,259 3,145 3,080 3,102 2,778 2,792 2,877 2,900 3,117 3,015 3,006 3,190 3,000 2,831 2,596 2,632 2,373 2,334 2,462 2,426
Accounts receivable, net 35,227 32,927 29,546 28,331 27,276 26,317 27,233 26,451 24,431 25,283 24,164 23,855 21,742 23,816 22,520 23,037 19,617 19,789 18,174 19,509
Inventories 18,025 17,954 17,291 18,263 19,090 18,058 17,375 18,160 17,760 17,399 16,979 17,618 18,496 17,478 16,519 16,976 17,516 16,028 15,511 15,448
Assets held for sale 620 625 908 1,498
Other current assets 3,151 3,074 3,412 3,767 2,685 2,479 2,541 5,530 5,292 5,319 5,291 5,458 5,277 5,830 6,002 6,232 5,113 4,841 4,691 4,578
Current assets 67,858 70,143 67,756 68,706 65,682 68,341 62,142 61,483 60,008 60,842 56,559 55,719 56,369 59,211 62,506 58,958 50,302 48,185 46,901 47,857
Long-term investments 23,019 21,667 22,114 21,612 21,096 20,565 21,124 22,595 23,025 22,370 22,136 21,025 20,812 20,216 18,594 16,840 17,314 17,342 16,973 16,410
Property and equipment, net 13,183 13,022 13,001 12,872 12,873 12,626 12,764 12,844 12,896 12,771 12,664 12,611 12,606 12,349 12,221 12,146 12,044 11,651 11,483 11,348
Operating lease right-of-use assets 17,252 17,564 17,703 17,660 17,872 18,270 18,562 18,801 19,122 20,462 20,476 20,542 20,729 20,484 20,571 20,672 20,860 20,757 20,865 20,992
Goodwill 91,272 91,261 91,260 84,057 78,150 78,086 78,560 79,060 79,121 79,121 79,552 79,552 79,552 79,579 80,057 79,993 79,749 79,548 79,485 79,075
Intangible assets, net 29,234 29,624 30,118 26,368 24,754 25,157 28,135 28,543 29,026 29,545 30,080 30,639 31,142 31,697 32,225 32,727 33,121 33,655 34,163 35,147
Separate accounts assets 3,250 3,200 3,267 3,231 3,228 3,318 4,140 4,670 5,087 5,086 4,880 4,692 4,881 4,793 4,639 4,555 4,459 4,590 4,271 4,074
Other assets 4,660 4,825 4,852 4,824 4,620 4,849 4,852 4,877 4,714 4,694 4,817 4,826 4,624 4,569 4,682 4,748 4,600 4,385 4,763 4,865
Long-term assets 181,870 181,163 182,315 170,624 162,593 162,871 168,137 171,390 172,991 174,049 174,605 173,887 174,346 173,687 172,989 171,681 172,147 171,928 172,003 171,911
Total assets 249,728 251,306 250,071 239,330 228,275 231,212 230,279 232,873 232,999 234,891 231,164 229,606 230,715 232,898 235,495 230,639 222,449 220,113 218,904 219,768

Based on: 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).


Assets: Selected Items

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. CVS Health Corp. current assets increased from Q2 2023 to Q3 2023 but then slightly decreased from Q3 2023 to Q4 2023 not reaching Q2 2023 level.
Property and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. CVS Health Corp. property and equipment, net increased from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023.
Long-term assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. CVS Health Corp. long-term assets decreased from Q2 2023 to Q3 2023 but then increased from Q3 2023 to Q4 2023 not reaching Q2 2023 level.
Total assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. CVS Health Corp. total assets increased from Q2 2023 to Q3 2023 but then decreased significantly from Q3 2023 to Q4 2023.

Current Assets: Selected Items

Balance sheet item Description The company
Cash and cash equivalents Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. CVS Health Corp. cash and cash equivalents decreased from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023.
Short-term investments Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. CVS Health Corp. short-term investments increased from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023.
Accounts receivable, net Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. CVS Health Corp. accounts receivable, net increased from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023.
Inventories Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. CVS Health Corp. inventories increased from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023.